key: cord-0797144-bzmaopx9 authors: Deitrick, Katie; Adams, Jourdan; Davis, Joshua title: Emergency Nursing Care of Patients with COVID-19 date: 2020-07-19 journal: J Emerg Nurs DOI: 10.1016/j.jen.2020.07.010 sha: f119a21660a2ff9ebecb3ed3f9dca668ce601496 doc_id: 797144 cord_uid: bzmaopx9 COVID-19 is the disease caused by the novel coronavirus originally from Wuhan, China. Its pathophysiology is poorly understood, but it is known to be contagious and deadly. Multiple symptoms and complications from the disease have been described, with the most common complaints being respiratory. Nursing care of patients with COVID-19 is largely supportive, but it should include a strong focus on mitigating the spread of infection to staff, other patients, and the community. Presentation 96 The majority of patients who present for medical care will have flu like symptoms (fever 42-97 91%, cough 50-86%, fatigue 51-70%, myalgias 35.4%, and shortness of breath 30%). 18,36-38 Other flu like symptoms of sore throat, headache, and stuffy nose are also known but less 99 common. 37 Cough seems to be the most common first symptom. 36 As little as 44% of patients 100 will have a documented fever on arrival, with 80-90% developing a fever during 101 hospitalization. 39 Subjective fevers appear to be a more common presentation. 102 Some more rare presentations of COVID-19 have been observed. Diarrhea seems to be a rare but 103 known presenting symptom, 7,40 but up to 70% of patients will develop some gastrointestinal 104 symptoms (nausea, vomiting, diarrhea, anorexia, abdominal pain, gastrointestinal bleeding). 41 Loss of smell (anosmia) and loss of taste (ageusia) are also known presentations of COVID- 19. 42 106 The viral incubation (time from exposure to symptoms) is typically 2-14 days. 36, 43 Most patients 107 will have contact with a person who is known or potentially positive for COVID-19, but as 108 disease incidence grows in certain areas, community spread can be presumed. That is, in areas 109 with very high incidence (e.g. New York City), all patients can be presumed to have had contact 110 with a person with COVID- 19. 111 For patients who develop severe illness, the need for hospitalization typically peaks around day 112 2-7 of symptoms, about day 10 after exposure. 38, 44 After admission, the small percentage of 113 patient who develop critical illness will do so remarkably rapidly. 39 Most commonly patients go 114 from minimal oxygen support to intubation within 24 hours. In the Emergency Department, nurses often encounter critically ill patients. The instinct of many 153 emergency nurses, in particular, is to run towards a critically ill patient and initiate assessment 154 and care. It is important that nurses and other healthcare workers take a couple extra seconds to 155 apply appropriate PPE prior to any resuscitation. This is supported by interim guidance from the 156 American Heart Association. 47 Nurses must care for themselves in order to be healthy and 157 available to care for future patients. Proper donning/doffing takes additional time and often requires additional staff member to assist 159 with doffing or acting as a runner to grab additional supplies, medications, and send lab tests. Our hospital encourages a "spotter", particularly during doffing, so any violations of sterility can 161 immediately be identified and remedied. We also use erasable markers to write messages to team 162 members outside the room on glass doors. Transport of patients will also need to be protocolized. This will need to be from triage to rooms 164 and within the hospital. For in hospital transport, careful consideration should be given to staff 165 needed, patient and staff PPE, and routes and elevators. Multiple staff will likely be needed for 166 transport. The primary initial evaluation of patients includes an adequate screening program. What this 169 includes will vary depending on burden of disease in a specific area. Many triage screening tools 170 for COVID-19 initially started with travel or known contact screening. More recently, areas with 171 a larger number of patients have switched to symptom-based screening system. Screening should include questions regarding known contacts but also places of residence, bearing in mind that 173 many congregate settings have been causes of rapid community spread. Any patient with fever or 174 respiratory symptoms should be wearing a mask or face cover of some sort. Ideally, a surgical 175 mask, but even cloth masks are acceptable in areas short on PPE for healthcare workers. Ambulance arrivals will need to be screened for COVID-19, as well. Clear communication with 177 pre-hospital staff prior to arrival and a standardized plan for transport for high and low risk 178 patients is needed. For example, we ask that high risk patients on CPAP or BiPAP be taken off of 179 this temporarily while they are being transported through the hallway from an ambulance to a 180 room. Our high-risk respiratory distress patients are then brought to directly to a negative 181 pressure room, ideally with necessary supplies and staff in appropriate PPE at bedside. These Regardless, a process to obtain and transport blood samples to the clinical laboratory is needed. Each laboratory or hospital may have different requirements. We initially did not use our 246 pneumatic tube system and had samples walked to the laboratory, but we have since started using 247 the tube system again. The nurse obtains the sample in the room and then deposits the labeled 248 samples in a specimen collection bag outside the room, held by a gloved, "clean" assistant. The Many of these patients progress to severe ARDS and need intubation. The presentation of ARDS 291 in these patients has been described as very atypical. 68 Ventilator settings should be low tidal 292 volume to avoid lung injury. 69 The ideal level of PEEP, though, continues to be debated, even among experts. 69 Patients with ARDS are frequently given steroids. Steroid treatment was 294 initially associated with increased mortality in some observational studies with COVID-19 and 295 was avoided; however, recent prospective data has shown steroids to be beneficial to patients 296 requiring supplemental oxygen or intubation. 70 In addition to elective proning of non-intubated 297 patient, proning is used in many intubated patients based on arterial blood gas findings. Proning Chloroquine is generally less tolerated than hydroxychloroquine due to worse side effects. Hydroxychloroquine is also used to treat autoimmune diseases like lupus and rheumatoid 310 arthritis. There is no overwhelming evidence that this drug works for COVID-19 in human trials. The most common side effect with this drug is QT prolongation, which can rarely lead to fatal Hydroxychloroquine, a less toxic derivative of chloroquine, is 600 effective in inhibiting SARS-CoV-2 infection in vitro Plaquenil® Hydroxychloroquine sulfate tablets, USP. United States Food and Drug Compassionate use of Remdesivir for patients with 606 severe COVID-19 A trial of Lopinavir-Ritonavir in adults hospitalized with 608 severe COVID-19 Convalescent plasma to treat COVID-19: Possibilities and 610 challenges Use of convalescent plasma therapy in SARS patients 613 in Hong Kong Convalescent transfusion for pandemic influenza: 615 preparing blood banks for a new plasma product? Treatment of 5 critically ill patients with COVID-19 with 617 convalescent plasma Zinc for the common cold Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc 622 ionophores block the replication of these viruses in cell culture A new clinical trial to test high-dose vitamin C in patients with COVID-19. Crit 625 Care Evidence that vitamin D supplementation 627 could reduce risk of influenza and COVID-19 infections and deaths COVID-19: Melatonin as a potential adjuvant treatment Abnormal coagulation parameters are associated with 632 poor prognosis in patients with novel coronavirus pneumonia Incidence of thrombotic complications 635 in critically ill ICU patients with COVID-19 Clinical pathology of critical patient with novel Coronavirus 637 Pneumonia (COVID-19) Acute pulmonary embolism and COVID-19 641 pneumonia: a random association? Use of sedative, analgesic, and neuromuscular blocking agents in the intensive care unit 643 during the novel 2019 coronavirus pandemic-Michigan Medical Guidelines. University of analgesia-and-NMB-guidelines-COVID-19-crisis-%20Michigan-Medicine-FINAL Preparing for the most critically ill patients with 648 COVID-19: The potential role of extracorporeal membrane oxygenation First successful treatment of COVID-19 induced 652 refractory cardiogenic plus vasoplegic shock by combination of pVAD and ECMO -A 653 Hospitalization and critical care of 109 decedents with COVID-655 19 pneumonia in Wuhan Fair allocation of scarce medical resources in 657 the time of COVID-19 To face coronavirus disease 2019, Surgeons must embrace 659 palliative care The importance of addressing advance care planning 662 and decisions about Do-Not-Resuscitate orders during novel coronavirus Covid-19: Doctors Are Told Not to Perform CPR on Patients 666 in Cardiac Arrest Hospitals consider universal do-not-resuscitate orders for coronavirus patients Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis The role of biomarkers in diagnosis of COVID-19 -A systematic review Laboratory abnormalities in patients with COVID-2019 infection Clinical course and risk factors for mortality of adult inpatients with COVID -19 in Wuhan, China: a retrospective cohort study D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 To the best of our knowledge, the authors have no conflicts of 673 interest, financial or other, to declare regarding this manuscript.